Laboratorio Farmaceutico Erfo SpA (IT:ERFO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Laboratorio Farmaceutico Erfo S.p.A., listed on Euronext Growth Milan, has acquired 4,000 shares as part of its ongoing buyback plan, representing 0.04% of its share capital. This latest purchase brings their total treasury shares to 5.44% of the share capital. The company continues to focus on expanding its business lines and enhancing its nutraceutical offerings.
For further insights into IT:ERFO stock, check out TipRanks’ Stock Analysis page.